Please login to the form below

Not currently logged in
Email:
Password:

company strategy

This page shows the latest company strategy news and features for those working in and with pharma, biotech and healthcare.

The Communiqué Awards: what are judges looking for?

The Communiqué Awards: what are judges looking for?

That’s why you have a strategy and set objectives because they can drive you on to great creativity.”. ... Among the judges were a senior leader in a behaviour change agency, a brand manager from a major pharma company, an SVP from a strategy agency,

Latest news

  • UCB signs research deal with King’s College London UCB signs research deal with King’s College London

    The shared workspace initiative builds on UCB’s global satellite search site strategy, which aims to embed company scientists within global centres of excellence. ... The biopharma company has already used the same approach in three US sites, resulting

  • Hardy returns to Genentech as CEO Hardy returns to Genentech as CEO

    Smith, who was the company’s chief operating officer, initially joined the company in 2001 from Ernst &Young. ... In 2019 and beyond, I am confident that we will continue to successfully execute the company’s long-standing strategy to bring

  • J&J earnings top expectations, but feels the squeeze in US J&J earnings top expectations, but feels the squeeze in US

    The company is hoping to retain a share of the prostate cancer market, however, via its new treatment Erleada. ... This includes the progression of digital surgery platforms, while capitalising on its portfolio and accelerating growth strategy.

  • Ex-Pharmacyclics CEO invests $25m in Summit Ex-Pharmacyclics CEO invests $25m in Summit

    says his involvement comes because he holds the company’s “management team and…strategy for developing innovative antibiotics for patients with serious infectious diseases in high-regard.”. ... The $25m investment in Summit is a relatively minor

  • Circassia seeks shift to AIM after failing LSE criteria Circassia seeks shift to AIM after failing LSE criteria

    The drug developer is planning to move to the AIM after failing to get its ‘free float’ – shares held by investors independent of the company – above the LSE’s required level ... The UK biotech insists there are benefits to moving to the AIM,

More from news
Approximately 51 fully matching, plus 126 partially matching documents found.

Latest Intelligence

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    Novartis’ collaborative culture. Fiona Bride. Fiona Bride, Director of Market Access Strategy, Novartis, says her company has shifted its culture to try to align as much as possible with healthcare providers,

  • How pharma should navigate Artificial Intelligence (AI) How pharma should navigate Artificial Intelligence (AI)

    Leaders need to develop an AI strategy that cuts through the hype and matches each company’s unique situation’. ... Given its clear benefits, leaders need to develop an AI strategy that cuts through the hype and matches each company’s unique

  • Revenue down the back of the beanbag Revenue down the back of the beanbag

    Transparency of the long-term business strategy, communication of company performance and creation of vehicles for shared wealth generation (such as well-designed bonus schemes and all employee stock plans) will ... so. Assuming that a graduate or

  • Understanding HCPs to build a meaningful brand Understanding HCPs to build a meaningful brand

    Net sentiment is the total of all such sentiment values assigned to mentions of the company. ... All those patients and HCPs that were among the most-mentioned Twitter accounts by pharmaceutical companies were also involved with the companies offline,

  • Patently unclear? Patently unclear?

    is vital to the long-term success of the company and, in the shorter term, having assets to showcase to potential investors. ... Clearly if useful patent protection is to be obtained in a biotech company’s target markets, the patenting strategy must

More from intelligence
Approximately 4 fully matching, plus 32 partially matching documents found.

Latest appointments

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    Flexion Therapeutics names chief strategy officer. Biopharmaceutical company Flexion Therapeutics has named Christina Willwerth as its chief strategy officer. ... Willwerth joined Flexion back in 2009 and most recently served as the company’s senior

  • Chameleon reveals new leadership line-up Chameleon reveals new leadership line-up

    He will report into Matt D’Auria, chief executive of Chameleon’s parent company Healthcare Consultancy Group. ... The company’s US executive vice president of commercial development, Guy Slatcher now moves into the role of president, Chameleon US.

  • Exelixis appoints Andrew Peters to newly created position Exelixis appoints Andrew Peters to newly created position

    In this newly created role, Peters will work with the Exelixis leadership team to refine the company’s mid- and long-term strategy, which is focused on advancing the next generation ... team as we work to identify potential future growth opportunities

  • Sue Mahony to retire as president of Lilly Oncology Sue Mahony to retire as president of Lilly Oncology

    She also most recently led the refocusing of the company’s oncology R&D strategy. ... Prior to this, as senior vice president of human resources and diversity, Mahony played in a role in restructuring the company into business units.

  • Neurimmune appoints chief business officer Neurimmune appoints chief business officer

    Fabian Buller will further drive the biopharma’s growth strategy. Monoclonal antibody-focused Neurimmune has appointed Fabian Buller into the newly created role of chief business officer. ... Roger Nitsch, president and CEO of Neurimmune, said: “We

More from appointments
Approximately 0 fully matching, plus 62 partially matching documents found.

Latest from PMHub

  • Practical Patient Centricity

    about their medicine is alien to us”.It is not just company strategy and intent that is the driving force for a more patient centric approach: external pressure is also building ... These may be outside the current scope of the company’s business, so

  • GK Strategy

    View LinkedIn profile. Edward Jones. Account Manager. View LinkedIn profile.  . GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? ... Read the full report here. “Lifeways Group and GK Strategy

  • IMARC Group

    IMARC is a leading market research company that offers management strategy and market research worldwide. ... Company Details.

  • Healthcare in the Digital Age

    also global director customer insights and strategy at medical device company Thermo Fisher Scientific.“Over the last ten years, pharmaceutical companies have become more selective, and did more and more segmentation

  • From ideals to execution – exploring the realities of patient-centricity

    We ran a 2-week online expert panel earlier this year, inviting our panel to discuss, as openly as possible, their company vision, the strategy and structure that they were putting

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics